Mark Moore

Company: Gempharmatech

Job title: Chief Executive Officer


Humanized Mouse Models for Development of Bispecific Antibody Therapeutics 9:35 am

– Discovering fully humanized CD3edg Mice – Understanding humanized checkpoint targets – Discussing tumor antigen targetsRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.